New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ADI;CTRX;DISCA;EQIX;LBTYA;LMCA;REGN;SBAC;VRSK;WDC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
May 29, 2015
06:07 EDTLBTYAVodafone shareholders 'open' to Liberty tie-up, Reuters reports
Subscribe for More Information
May 28, 2015
14:21 EDTWDCWestern Digital shares jump after Goldman Sachs upgrade
Subscribe for More Information
11:58 EDTADISemtech hits 52-week low after Q1 results, Q2 outlook miss expectations
Shares of Semtech Corporation (SMTC), a supplier of analog and mixed-signal semiconductor products, are falling after the companyís first quarter results and second quarter outlook trailed analysts' consensus estimates. WHAT'S NEW: Semtech yesterday reported Q1 earnings per share of 27c excluding items and revenue of $130.1M, trailing analysts' consensus estimates of 28c and $132.51M, respectively. Semtech reported Q1 adjusted gross margin of 60.8%. The company also said it increased its stock buyback authorization to $100M. It had $30M remaining under a previous buyback plan. Looking ahead to Q2, Semtech forecast adjusted EPS of 21c-26c and revenue of $120M-$130M, well below analysts' consensus estimates of 37c and $1.41.65M, respectively. The company also forecast Q2 adjusted gross profit margin of 60%-60.4%. WHAT'S NOTABLE: Mohan Maheswaran, the company's Chief Executive Officer, noted that Semtech saw strong demand in Q1 from its enterprise computing and communication end-markets driven by the datacenter and PON market segments. However, Maheswaran said that demand from its largest smartphone customer was "much lower than anticipated," which led to results that were at the lower end of its guidance range. Semtech previously projected Q1 EPS of 27c-30c and revenue of $130M-$136M. Maheswaran said demand for the company's LoRa wireless platforms is seeing an acceleration. ANALYST REACTION: This morning, research firm B. Riley downgraded Semtech to Sell from Neutral after the company's Q1 results missed expectations. The firm cut its price target for shares to $21 from $26. OTHERS TO WATCH: Other companies in the in the analog and mixed-signal semiconductor space include Texas Instruments (TXN), Maxim Integrated Products (MXIM) and Analog Devices (ADI). PRICE ACTION: In late morning trading, Semtech fell $3.41, or nearly 14%, to $21.21 on nearly five times its average daily trading volume. The stock continues to hit fresh 52-week lows during the session. Including today's pull back, the shares have lost approximately 18% over the past 12 months.
11:15 EDTLBTYAOptions with increasing implied volatility
Subscribe for More Information
10:02 EDTWDCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:27 EDTWDCOn The Fly: Pre-market Movers
HIGHER: Rally Software (RALY), up 44% after deal to be bought by CA Technologies for $19.50 per share... IMAX (IMAX), up 6.5% after IMAX China files application for IPO on Hong Kong Stock Exchange... Avago (AVGO), up 2.8% after announcing deal to buy Broadcom (BRCM) for $37B in cash and stock. Broadcom shares are down 1% following the announcement... Western Digital (WDC), up 2.4% following upgrade to Buy from Neutral at Goldman. UP AFTER EARNINGS: Express (EXPR), up 8%... Abercrombie & Fitch (ANF), up 4.3%. LOWER: NeoStem (NBS), down 22.8% after 12.5M share secondary price at $2 per share... Ctrip.com (CTRP), down 1.6% after reportedly disclosing cyberattack against its services. DOWN AFTER EARNINGS: Orbital ATK (OA), down 1.6%... Signet (SIG), down 3.5%... Sanderson Farms (SAFM), down 3%... Dangdang (DANG), down 11%.
05:53 EDTWDCWestern Digital upgraded to Buy from Neutral at Goldman
Goldman Sachs analyst Bill Shope upgraded Western Digital (WDC) to Buy from Neutral saying concerns over the weak PC market are overdone. Shope points out that Western Digital's business is increasingly dependent on non-PC Exabyte growth. He also notes Goldman's leveraged buyout model finds a 14.3% base case internal rate of return. The analyst raised his price target for shares to $122 from $106. The data storage solutions company closed yesterday up $1.18 to $94.37. Its peer Seagate (STX), which Shope says Western Digital trades at a discount to, closed yesterday up 75c to $55.34.
May 27, 2015
10:06 EDTLBTYAHigh option volume stocks
Subscribe for More Information
08:46 EDTVRSKVerisk Analytics fits criteria for addition to S&P 500 Index, says Baird
Subscribe for More Information
May 26, 2015
20:50 EDTADIBernstein to hold a conference
Subscribe for More Information
11:54 EDTLBTYAOptions with increasing implied volatility
Options with increasing implied volatility: VIPS DGX CVC JIVE LBTYA BBBY YHOO NKE CAN DTV
09:03 EDTEQIXInterXion upgraded on M&A potential, valuation at Stifel
Subscribe for More Information
07:03 EDTLBTYAVodafone investors would support deal with Liberty Global, Telegraph reports
Subscribe for More Information
05:23 EDTEQIXEquinix to invest over $40M to expand in Hong Kong
Subscribe for More Information
May 22, 2015
10:19 EDTLBTYAOptions with increasing implied volatility
Subscribe for More Information
06:53 EDTLBTYAVodafone more likely an asset seller than buyer, says Goldman
Subscribe for More Information
05:52 EDTLBTYAStocks with implied volatility movement; MRVL LBYTA
Stocks with implied volatility movement; Marvell (MRVL) 40, Liberty Global (LBTYA) 28 according to iVolatility.
May 21, 2015
14:48 EDTREGNRegeneron primary driver remains Praluent, says Piper Jaffray
Piper Jaffray noted that Regeneron (REGN) shares are at all-time highs after the company and partner Sanofi reported Phase IIb data on Dupilumab and Phase III data on Sarilumab. However, the firm believes the primary driver for Regeneron remains Praluent and firm expects launch costs to outstrip sales growth. Piper acknowledges Regeneron has "one of the richest pipelines in all of biotech," but it sees risk around Amgen's (AMGN) patent suit and keeps its Neutral rating and $484 price target on the stock.
10:04 EDTLBTYAHigh option volume stocks
High option volume stocks: MTZ LQD LBTYA AGEN OCR CVC NTAP BBY BRKR VOC
09:58 EDTEQIXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:49 EDTEQIXEquinix downgraded to Hold from Buy at Gabelli (pre--open)
Subscribe for More Information
06:29 EDTEQIXEquinix downgraded to Hold from Buy at Stifel
Stifel downgraded Equinix to Hold based on valuation and lack of catalysts.
05:49 EDTLBTYAVodafone upgraded to Neutral from Reduce at Nomura
Nomura upgraded Vodafone (VOD) to Neutral saying the company's board should consider alternatives following Liberty Global's (LBTYA) public interest in a combination.
05:15 EDTREGNRegeneron, Sanofi announce positive topline results from sarilumab Phase 3 study
Subscribe for More Information
May 20, 2015
08:53 EDTREGNRegeneron price target raised to $560 from $500 at Argus
Argus increased its price target on Regeneron as the firm notes that the company has had positive pipeline and earnings news over the past year, and has increased its sales outlook. Argus thinks the company has a strong pipeline and keeps a Buy rating on the shares.
08:24 EDTADIAnalog Devices price target raised to $72 from $62 at Oppenheimer
Subscribe for More Information
08:04 EDTEQIXEquinix receives favorable REIT private letter ruling from IRS
Subscribe for More Information
07:58 EDTLBTYAVodafone volatility elevated, Liberty Global chairman talkís potential synergies
Subscribe for More Information
07:38 EDTREGNRegeneron price target raised to $600 from $525 at Canaccord
Canaccord raised its price target on Regeneron to $600 from $525 following positive top-line data for its Phase 2b study of dupilumab in adult patients with moderate-to-severe asthma. The firm sees the data as significant, as it reinforces the role of dupilumab and increases the potential future revenue stream for the company. Canaccord reiterated its Buy rating on Regeneron shares.
07:36 EDTADIJPMorgan to hold a conference
Subscribe for More Information
May 19, 2015
16:19 EDTVRSKVerisk Analytics sees Wood Mackenzie acquisition accretive to 2H15 EPS by 8c-10c
Subscribe for More Information
16:02 EDTADIAnalog Devices sees Q3 adjusted EPS 71c-77c, consensus 77c
Subscribe for More Information
16:01 EDTADIAnalog Devices reports Q2 adjusted EPS 73c, consensus 72c
Subscribe for More Information
15:26 EDTLBTYALiberty Global chairman calls Vodafone 'great fit' for company, Bloomberg says
In a Bloomberg telephone interview, Liberty Global (LBTYA) chairman John Malone said he believes a combination with Vodafone (VOD) would be a "great fit" for Liberty's western European operations. "There would be very substantial synergies if we could find a way to work together or combine the companies with respect to western Europe," said Malone, who emphasized potential synergies in the U.K., Germany, and the Netherlands. "The principal barrier to us... [is that Vodafone's] philosophy is low leverage, low risk and high cash payout to their shareholders. I prefer to grow equity value," remarked Malone, cautioning that "Iím talking philosophically here... Iím not making an offer to anybody." The chairman also specified that Liberty "would buy" -- as phrased by Bloomberg -- mobile operators in countries such as the Netherlands, where its presence is sufficiently large. Reference Link
15:00 EDTADINotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Analog Devices (ADI), consensus 72c... Autodesk (ADSK), consensus 28c... Computer Sciences Corporation (CSC), consensus $1.20... Qihoo 360 Technology (QIHU), consensus 49c... Keysight Technologies (KEYS), consensus 65c... Nordson (NDSN), consensus 86c... ViaSat (VSAT), consensus 42c... Dycom Industries (DY), consensus 37c.
15:00 EDTLBTYAMalone: Liberty makes 'great fit' with Vodafone in West Europe, Bloomberg says
Subscribe for More Information
12:55 EDTWDCPC related stocks struggle after Morgan Stanley says PC turn won't come until Q3
Subscribe for More Information
08:33 EDTWDCMorgan Stanley cautious in near-term on PC names
Morgan Stanley is more cautious on PC names near-term, given PC and HDD inventory builds quarter-to-date and weaker April ODM sales. The firm's analyst team continues to believe Q1 was a bottom in year-over-year growth, but now expects normal Q2 seasonal growth instead of above normal and thinks any recovery will likely be delayed until Q3. Morgan Stanley is cautiously optimistic on Western Digital (WDC) due to its diverse revenue drivers, sees value creation catalysts for Hewlett-Packard (HPQ) and believes Microsoft (MSFT) shares reflect the challenging PC market and Win 10. The firm is more cautious on semis such as NVIDIA (NVDA) given higher valuations, share loss at Advanced Micro (AMD), potential 2H margin pressure at Intel (INTC), and Morgan is cautious on PC DRAM stocks near-term due to weaker pricing.
07:43 EDTSBACJPMorgan to hold a conference
Subscribe for More Information
May 18, 2015
12:34 EDTREGNRegeneron, Sanofi announce positive pivotal Phase 2b dupilumab data in asthma
Subscribe for More Information
10:47 EDTCTRXOptions with increasing implied volatility: KNDI CTRX
Subscribe for More Information
May 15, 2015
17:15 EDTEQIXPaulson & Co. gives quarterly update on stakes
Subscribe for More Information
10:34 EDTCTRXOptions with increasing implied volatility
Subscribe for More Information
10:13 EDTLBTYAHigh option volume stocks
High option volume stocks: POST SFM GSVC HGG HUN PH JWN CAR ONTY LBTYA
08:15 EDTREGNRegeneron target upped to $550 at Credit Suisse citing growth potential
Subscribe for More Information
08:04 EDTREGNRegeneron price target raised to $450 from $427 at JPMorgan
JPMorgan said it is "increasingly confident" in dupilumab's longer-term prospects in asthma ahead of the full Phase 2b results. The firm believes the drug's peak sales could top $4B. JPMorgan keeps a Neutral rating on Regeneron, however, saying its valuation already reflects blockbuster sales for Eylea, Praluent, sarilumab and dupilumab. It raised its price target for the name to $450 from $427.
07:04 EDTWDCWestern Digital can reach $10+ EPS in fiscal 2017, says RBC Capital
Subscribe for More Information
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use